This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Medidata Solutions, Inc.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Andrew Kopelman: Innovator in Remote Clinical Study Monitoring
Introduction
Andrew Kopelman is a notable inventor based in New York, NY (US). He has made significant contributions to the field of clinical research through his innovative patent. His work focuses on enhancing the quality and efficiency of remote clinical study site monitoring.
Latest Patents
Kopelman's most recent patent is titled "Remote clinical study site monitoring and data quality scoring." This invention outlines a method for remote site monitoring that includes receiving data from a data site, converting those data into a site-level quality score using a metric risk profile, and calculating a risk indicator based on the site-level quality score. The metric risk profile may be based on historic data and study data, where the study data is received from a plurality of data sites. In some embodiments, converting the data includes normalizing a value of a metric by applying to it the metric risk profile and aggregating the normalized metric values to calculate the site-level quality score. An apparatus for remote site monitoring is also described in the patent.
Career Highlights
Andrew Kopelman is currently associated with Medidata Solutions, Inc., a company that specializes in providing cloud-based solutions for clinical research. His role at Medidata Solutions allows him to leverage his expertise in data quality and monitoring to improve clinical trial outcomes.
Collaborations
Kopelman has worked alongside talented professionals such as Stephen Young and Mladen Laudanovic. Their collaborative efforts contribute to the advancement of innovative solutions in the clinical research sector.
Conclusion
Andrew Kopelman is a key figure in the realm of remote clinical study monitoring, with a patent that showcases his innovative approach to enhancing data quality and site monitoring. His contributions are vital for the future of clinical research and data management.